Resource Logo
NLM AIDSLINE

Oropharyngeal and esophageal candidiasis in HIV disease: emerging pathogens, changing therapies.




 

Aids Patient Care STDS. 1997 Feb;11 Suppl 1:S1-25; quiz S26-7. Unique

*Antifungal Agents/THERAPEUTIC USE *AIDS-Related Opportunistic Infections/DRUG THERAPY *AIDS-Related Opportunistic Infections/MICROBIOLOGY *Candidiasis, Oral/DRUG THERAPY *Candidiasis, Oral/MICROBIOLOGY



 




Information in this article was accurate in September 30, 1997. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.